Lantern Pharma (LTRN) Debt Ratio (2020)

Lantern Pharma's (LTRN) quarterly Debt Ratio came in at 0.0 in Q2 2020.

Lantern Pharma (LTRN) Debt Ratio (2020) Analysis & Trends

Lantern Pharma (LTRN) has 1 years of Debt Ratio data on file, last reported at 0.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	138.81 Bn	130.96 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.07 Bn	78.08 Bn	3.93 Bn	0.05
3	Argenx Se	65.47 Bn	60.29 Bn	1.37 Bn	-
4	Moderna	55.64 Bn	50.50 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.99 Bn	36.89 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.68 Bn	28.37 Bn	992.69 Mn	-
7	BioNTech SE	27.69 Bn	9.29 Bn	668.28 Mn	0.03
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.36 Bn	26.52 Bn	-	0.47
10	Lantern Pharma	26.22 Mn	26.22 Mn	-	-

Download Data

Date	Value
Jun 30, 2020	0.00